Rare diseases
Investigational molecules
Locations
Route De La Corniche 3b, 1066
The organization concentrates on developing targeted therapies for patients with blood cancers, particularly focusing on B-cell lymphomas and related malignancies. Research efforts encompass multiple subtypes of non-Hodgkin lymphoma, including diffuse large B-cell lymphoma (DLBCL), follicular lymphoma, and mantle cell lymphoma. Investigations extend to aggressive forms such as transformed follicular lymphoma and high-grade B-cell lymphoma.
The therapeutic portfolio addresses both previously treated patients and those who have experienced disease progression after multiple prior lines of therapy, with particular attention to populations with limited treatment options.
ADC Therapeutics SA runs clinical trials in conditions such as Diffuse large B-cell lymphoma, Neoplasm malignant, among others.
Clinical trials registered by this sponsor – none is enrolling right now.
Spain
Belgium
ItalyIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
